Stay updated on Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial

Sign up to get notified when there's something new on the Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    No additions or deletions are reported, indicating that the page content shown by this input remains unchanged.
    Difference
    0.1%
    Check dated 2026-07-18T04:33:34.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    No changes are reported for this page based on the provided data; the Study Details page remains unchanged.
    Difference
    0.1%
    Check dated 2026-07-11T00:13:58.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.3 in the footer, replacing v3.6.2. This indicates a minor platform update rather than changes to the study details or visible content.
    Difference
    0.0%
    Check dated 2026-07-03T22:00:22.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, indicating a minor internal update to the page's template or scripts. The visible study details and user interactions remain unchanged.
    Difference
    0.0%
    Check dated 2026-06-26T20:25:37.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Added recruitment status message 'No longer looking for participants' and new user guidance pages (How to Read a Study Record, Common Questions, How to Join a Study). Reformatted the Intervention/Treatment heading and updated the revision from v3.5.5 to v3.6.0.
    Difference
    0.2%
    Check dated 2026-06-12T16:20:27.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The record now indicates that results were posted (2026-06-04) and includes expanded trial design, endpoints, and PK data for the CPI-0610 studies, providing deeper context about the study and its outcomes.
    Difference
    6%
    Check dated 2026-06-05T11:31:38.000Z thumbnail image

Stay in the know with updates to Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial page.